| Literature DB >> 31135381 |
Yu Zhang1,2, Rong-Bei Liu2, Qian Cao2, Ke-Qi Fan1, Ling-Jie Huang2, Jian-Shuai Yu1, Zheng-Jun Gao1, Tao Huang1, Jiang-Yan Zhong1, Xin-Tao Mao1, Fei Wang1, Peng Xiao2, Yuan Zhao2, Xin-Hua Feng1, Yi-Yuan Li1, Jin Jin1,2,3.
Abstract
Calcineurin acts as a calcium-activated phosphatase that dephosphorylates various substrates, including members of the nuclear factor of activated T cells (NFAT) family, to trigger their nuclear translocation and transcriptional activity. However, the detailed mechanism regulating the recruitment of NFATs to calcineurin remains poorly understood. Here, we report that calcineurin A (CNA), encoded by PPP3CB or PPP3CC, is constitutively ubiquitinated on lysine 327, and this polyubiquitin chain is rapidly removed by ubiquitin carboxyl-terminal hydrolase 16 (USP16) in response to intracellular calcium stimulation. The K29-linked ubiquitination of CNA impairs NFAT recruitment and transcription of NFAT-targeted genes. USP16 deficiency prevents calcium-triggered deubiquitination of CNA in a manner consistent with defective maintenance and proliferation of peripheral T cells. T cell-specific USP16 knockout mice exhibit reduced severity of experimental autoimmune encephalitis and inflammatory bowel disease. Our data reveal the physiological function of CNA ubiquitination and its deubiquitinase USP16 in peripheral T cells. Notably, our results highlight a critical mechanism for the regulation of calcineurin activity and a novel immunosuppressive drug target for the treatment of autoimmune diseases.Entities:
Keywords: Calcium signaling; Cell Biology; Immunology; T cells; Ubiquitin-proteosome system
Year: 2019 PMID: 31135381 PMCID: PMC6597231 DOI: 10.1172/JCI123801
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808